(864) 370-3297

info@glytecsystems.com

(864) 370-3297

info@glytecsystems.com

Image
  • About
    • About Glytec
    • Executive Team
    • Board of Directors
    • Scientific Advisory Board
    • Newsroom
    • Careers
  • Solutions
    • eGlycemic Management System
    • Implementation & Support
    • Quality Initiatives
    • Sliding Scale to Basal Bolus Transition
  • Resources
    • All Resources
    • Hospital Pharmacy Resources
    • CMS’s Hospital Harm Measures on Severe Hypo and Hyperglycemia
    • Nurse Resources
    • Evidence
  • Case Studies
  • Blog
  • Events & Webinars
  • Contact
Menu
View Post

March 30, 2022

Enhancing Diabetes Care with Technology: Key Strategies from Emory University and Grady Health System

In by Alexa DriscollMarch 30, 2022

Discuss how Grady Health System rose to the challenge of COVID-19 and accelerated changes in glycemic management across their system preparing them for the future of diabetes care

Read More
View Post

February 10, 2022

Inpatient Insulin Basics: How to Safely Transition Between IV Insulin and SubQ Insulin

In by Alexa DriscollFebruary 10, 2022

This guide answers key questions around how to safely transition patients with hyperglycemia from intravenous (IV) to subcutaneous (SubQ) insulin.

Read More
 

Subscribe to our blog

Image
Glytec is the insulin management software company for healthcare providers focused on improving the quality and cost of care. Its FDA-cleared titration software and proprietary algorithms power the only solution capable of delivering personalized diabetes treatment recommendations across the continuum of care, from hospital to home. With ongoing support from its team of doctors, nurses and technologists headquartered outside of Boston, Glytec improves outcomes and controls costs for the large population of patients requiring insulin treatment – including those with and without a diagnosis of diabetes.

©Copyright Glytec, LLC on behalf of Aseko, Inc. | Terms of Use | Legal Disclaimer | Privacy Policy | Contraindications, Warnings and Precautions

The eGlycemic Management System® is a modularized solution for glycemic management across the care continuum that includes Glucommander™. Glucommander™ is a prescription-only software medical device for glycemic management intended to evaluate current as well as cumulative patient blood glucose values coupled with patient information including age, weight and height, and, based on the aggregate of these measurement parameters, whether one or many, recommend an IV dosage of insulin, glucose or saline or a subcutaneous basal and bolus insulin dosing recommendation to adjust and maintain the blood glucose level towards a configurable physician- determined target range. Glucommander™ is indicated for use in adult and pediatric (ages 2-17 years) patients. The measurements and calculations generated are intended to be used by qualified and trained medical personnel in evaluating patient conditions in conjunction with clinical history, symptoms, and other diagnostic measurements, as well as the medical professional’s clinical judgement. No medical decision should be based solely on the recommended guidance provided by this software program.

Glucommander™ is only available for use in the United States.

This site is only intended for use in the United States.

Aseko is a registered trademark of Aseko, Inc.

Image
Image
  • About
    • ← Back
    • About Glytec
    • Executive Team
    • Board of Directors
    • Scientific Advisory Board
    • Newsroom
    • Careers
  • Solutions
    • ← Back
    • eGlycemic Management System
    • Implementation & Support
    • Quality Initiatives
    • Sliding Scale to Basal Bolus Transition
  • Resources
    • ← Back
    • All Resources
    • Hospital Pharmacy Resources
    • CMS’s Hospital Harm Measures on Severe Hypo and Hyperglycemia
    • Nurse Resources
    • Evidence
  • Case Studies
  • Blog
  • Events & Webinars
  • Contact